Wednesday, September 16, 2009 - Day 3
| Track D |
|---|
|
8:30 - 9:30
Biotech Company Outsourcing Culture: Pricing, Timing, Speed, Quality and Frequent Change
Firoz D. Antia, Ph.D.
Executive Director Product Development
Palatin Technologies, Inc.
Brian S. Bronk, Ph.D.
Vice President of Chemistry
Satori Pharmaceuticals Inc.
Bob Edmonston
Associate Director, API Development Sourcing
Alkermes, Inc.
Hui-Yin (Harry) Li, Ph.D.
President
Wilmington PharmaTech
Bernhard J. Paul, Ph.D.
Associate Director, Process Chemistry
Johnson Mathey Pharma Services
10:45 - 11:45
Small Molecule Bio-Tech Company Approaches to Contracts, IP and Reports
David Fick, Ph.D.
Director, Medicinal Chemistry
Cenomed Biosciences
Brian Scanlon
Vice President
Cambridge Major Laboratories
Michael Williams, Ph.D.
Director, Pharmaceutical Research & Development
Targacept, Inc.
Shuguang Zhu, Ph.D.
President
Apincon
1:00 - 2:00
Biotech Small Molecule API Sourcing: CMO Value Proposition vs. Customer Needs
Zhengming (Jimmy) Chen, Ph.D.
Chemistry and API Consultant
Aton Pharma, Inc.
Luca Parlanti, Ph.D.
Head of Sales & Business Development North America-Custom Synthesis
BASF
Peng Wang, Ph.D.
Senior Manager, Process Chemistry
Phenomix Corporation
Ben Yerxa, Ph.D.
Executive Vice President & Chief, Research & Development
Inspire Pharmaceuticals
2:00 - 3:00
I Have to Scale Up to 20 Kilos in 6 Months How Can I Get This Done
Umar Hayat, Ph.D.
Senior Manager, CMC
Anacor Pharmaceuticals
Deborah Minor, Ph.D.
President
Drug Discovery Alliances
Jan Oudenes, Ph.D.
President & CEO
Alphora Research
Brian Scanlon
Vice President
Cambridge Major Laboratories
Andrew Thompson, Ph.D.
President
J-Star Research
3:00 - 4:00
Small Molecule Bio-Tech Vendor Selection Criteria
Stuart Levy, Ph.D.
Principal
SGL Chemistry Consulting
Stuart Needleman
President, API Development and Manufacturing
Aptuit
Silvina Garcia Rubio, Ph.D.
Senior Director, Technical Affairs
Helsinn Therapeutics US, Inc.
Shuguang Zhu, Ph.D.
President
Apincon
|